Spain· ES:60917
BILINA 0,5 mg/ml COLIRIO EN SUSPENSIÓN
A medicinal product containing levocabastina, registered in Spain by Esteve Pharmaceuticals S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- levocabastina
- Manufacturer
- Esteve Pharmaceuticals S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo6821204EUR 7.73
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Levocabastina in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyLevocabastinDermapharm Ag
- United KingdomLivostin 0.05% nasal sprayNovartis Pharmaceuticals UK Ltd
- FranceALLERGIFLASH 0,05 %, collyre en solutionLABORATOIRE CHAUVIN
- SwedenLivocab 50 mikrogram/dos Nässpray, suspensionOrifarm AB
- FinlandLivostinParanova Oy
- BelgiumLivostin 0.5 mg/mlOrifarm
- IcelandLivostinMcNeil Sweden AB
- NorwayLivostinMcNeil Sweden AB
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Levocamed, Livostin
- Belgium · Livostin, Nasasinuspray Anti-Allergie
- Czechia · Livostin
- Germany · Levocabastin, Levocamed
- Denmark · Benaliv
- Finland · Livostin
- France · Allergiflash, Levofree
- Greece · Livostin
- Iceland · Livostin
- Italy · Levoreact, Levoreact Oftalmico
- Luxembourg · Livostin, Nasasinuspray Anti-Allergie
- Netherlands · Livocab
- Norway · Livostin
- Sweden · Livostin
- Slovakia · Livostin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4d9a257f-726f-4e00-bccc-c5f41861eae1 GET /v1/drugs/4d9a257f-726f-4e00-bccc-c5f41861eae1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":836172000000}",
"nregistro": "60917",
"substance": "levocabastina"
}See everything about levocabastina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.